{
    "nctId": "NCT05768451",
    "briefTitle": "Ultrasound Radiomics for Predicting Breast Cancer and Axillary Lymph Node Metastasis",
    "officialTitle": "Accurate Prediction of Breast Cancer and Axillary Lymph Node Metastasis Burden by Multi-modal Ultrasound-based Radiomics",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer, Axillary Lymph Node Metastasis",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Accuracy of differential diagnosis between benign and malignant",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* patients who have not received breast puncture biopsy or neoadjuvant chemotherapy, etc. prior to ultrasonography;\n* patients who are not allergic to the ultrasound contrast agent (SonoVue) and have signed an informed consent form for ultrasonography\n* patients with breast tumors who have undergone surgical treatment at our hospital and have complete case histories.\n\nExclusion Criteria:\n\n* patients with incomplete case data;\n* cases with large breast masses that do not completely show the region of interest (ROI);\n* patients who have undergone breast aspiration biopsy or other treatments such as neoadjuvant chemotherapy or endocrine therapy before ultrasound examination.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}